Global Vaccines Administered Orally Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vaccines Administered Orally Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Vaccines Administered Orally by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Vaccines Administered Orally by Country/Region, 2017, 2022 & 2028

2.2 Vaccines Administered Orally Segment by Type

2.2.1 Human

2.2.2 Animal

2.3 Vaccines Administered Orally Sales by Type

2.3.1 Global Vaccines Administered Orally Sales Market Share by Type (2017-2022)

2.3.2 Global Vaccines Administered Orally Revenue and Market Share by Type (2017-2022)

2.3.3 Global Vaccines Administered Orally Sale Price by Type (2017-2022)

2.4 Vaccines Administered Orally Segment by Application

2.4.1 Public

2.4.2 Private

2.5 Vaccines Administered Orally Sales by Application

2.5.1 Global Vaccines Administered Orally Sale Market Share by Application (2017-2022)

2.5.2 Global Vaccines Administered Orally Revenue and Market Share by Application (2017-2022)

2.5.3 Global Vaccines Administered Orally Sale Price by Application (2017-2022)

3 Global Vaccines Administered Orally by Company

3.1 Global Vaccines Administered Orally Breakdown Data by Company

3.1.1 Global Vaccines Administered Orally Annual Sales by Company (2020-2022)

3.1.2 Global Vaccines Administered Orally Sales Market Share by Company (2020-2022)

3.2 Global Vaccines Administered Orally Annual Revenue by Company (2020-2022)

3.2.1 Global Vaccines Administered Orally Revenue by Company (2020-2022)

3.2.2 Global Vaccines Administered Orally Revenue Market Share by Company (2020-2022)

3.3 Global Vaccines Administered Orally Sale Price by Company

3.4 Key Manufacturers Vaccines Administered Orally Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vaccines Administered Orally Product Location Distribution

3.4.2 Players Vaccines Administered Orally Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Vaccines Administered Orally by Geographic Region

4.1 World Historic Vaccines Administered Orally Market Size by Geographic Region (2017-2022)

4.1.1 Global Vaccines Administered Orally Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Vaccines Administered Orally Annual Revenue by Geographic Region

4.2 World Historic Vaccines Administered Orally Market Size by Country/Region (2017-2022)

4.2.1 Global Vaccines Administered Orally Annual Sales by Country/Region (2017-2022)

4.2.2 Global Vaccines Administered Orally Annual Revenue by Country/Region

4.3 Americas Vaccines Administered Orally Sales Growth

4.4 APAC Vaccines Administered Orally Sales Growth

4.5 Europe Vaccines Administered Orally Sales Growth

4.6 Middle East & Africa Vaccines Administered Orally Sales Growth

5 Americas

5.1 Americas Vaccines Administered Orally Sales by Country

5.1.1 Americas Vaccines Administered Orally Sales by Country (2017-2022)

5.1.2 Americas Vaccines Administered Orally Revenue by Country (2017-2022)

5.2 Americas Vaccines Administered Orally Sales by Type

5.3 Americas Vaccines Administered Orally Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vaccines Administered Orally Sales by Region

6.1.1 APAC Vaccines Administered Orally Sales by Region (2017-2022)

6.1.2 APAC Vaccines Administered Orally Revenue by Region (2017-2022)

6.2 APAC Vaccines Administered Orally Sales by Type

6.3 APAC Vaccines Administered Orally Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Vaccines Administered Orally by Country

7.1.1 Europe Vaccines Administered Orally Sales by Country (2017-2022)

7.1.2 Europe Vaccines Administered Orally Revenue by Country (2017-2022)

7.2 Europe Vaccines Administered Orally Sales by Type

7.3 Europe Vaccines Administered Orally Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vaccines Administered Orally by Country

8.1.1 Middle East & Africa Vaccines Administered Orally Sales by Country (2017-2022)

8.1.2 Middle East & Africa Vaccines Administered Orally Revenue by Country (2017-2022)

8.2 Middle East & Africa Vaccines Administered Orally Sales by Type

8.3 Middle East & Africa Vaccines Administered Orally Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Vaccines Administered Orally

10.3 Manufacturing Process Analysis of Vaccines Administered Orally

10.4 Industry Chain Structure of Vaccines Administered Orally

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Vaccines Administered Orally Distributors

11.3 Vaccines Administered Orally Customer

12 World Forecast Review for Vaccines Administered Orally by Geographic Region

12.1 Global Vaccines Administered Orally Market Size Forecast by Region

12.1.1 Global Vaccines Administered Orally Forecast by Region (2023-2028)

12.1.2 Global Vaccines Administered Orally Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Vaccines Administered Orally Forecast by Type

12.7 Global Vaccines Administered Orally Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Vaccines Administered Orally Product Offered

13.1.3 Merck Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 GSK

13.2.1 GSK Company Information

13.2.2 GSK Vaccines Administered Orally Product Offered

13.2.3 GSK Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK Main Business Overview

13.2.5 GSK Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi Vaccines Administered Orally Product Offered

13.3.3 Sanofi Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Lanzhou Institute

13.4.1 Lanzhou Institute Company Information

13.4.2 Lanzhou Institute Vaccines Administered Orally Product Offered

13.4.3 Lanzhou Institute Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Lanzhou Institute Main Business Overview

13.4.5 Lanzhou Institute Latest Developments

13.5 Serum Institute

13.5.1 Serum Institute Company Information

13.5.2 Serum Institute Vaccines Administered Orally Product Offered

13.5.3 Serum Institute Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Serum Institute Main Business Overview

13.5.5 Serum Institute Latest Developments

13.6 Valneva

13.6.1 Valneva Company Information

13.6.2 Valneva Vaccines Administered Orally Product Offered

13.6.3 Valneva Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Valneva Main Business Overview

13.6.5 Valneva Latest Developments

13.7 Shanghai United Cell

13.7.1 Shanghai United Cell Company Information

13.7.2 Shanghai United Cell Vaccines Administered Orally Product Offered

13.7.3 Shanghai United Cell Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Shanghai United Cell Main Business Overview

13.7.5 Shanghai United Cell Latest Developments

13.8 Bibcol

13.8.1 Bibcol Company Information

13.8.2 Bibcol Vaccines Administered Orally Product Offered

13.8.3 Bibcol Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bibcol Main Business Overview

13.8.5 Bibcol Latest Developments

13.9 PaxVax

13.9.1 PaxVax Company Information

13.9.2 PaxVax Vaccines Administered Orally Product Offered

13.9.3 PaxVax Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 PaxVax Main Business Overview

13.9.5 PaxVax Latest Developments

13.10 Vabiotech

13.10.1 Vabiotech Company Information

13.10.2 Vabiotech Vaccines Administered Orally Product Offered

13.10.3 Vabiotech Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Vabiotech Main Business Overview

13.10.5 Vabiotech Latest Developments

13.11 Tiantan Biological

13.11.1 Tiantan Biological Company Information

13.11.2 Tiantan Biological Vaccines Administered Orally Product Offered

13.11.3 Tiantan Biological Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Tiantan Biological Main Business Overview

13.11.5 Tiantan Biological Latest Developments

13.12 EuBiologics

13.12.1 EuBiologics Company Information

13.12.2 EuBiologics Vaccines Administered Orally Product Offered

13.12.3 EuBiologics Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 EuBiologics Main Business Overview

13.12.5 EuBiologics Latest Developments

13.13 Panacea Biotec Ltd

13.13.1 Panacea Biotec Ltd Company Information

13.13.2 Panacea Biotec Ltd Vaccines Administered Orally Product Offered

13.13.3 Panacea Biotec Ltd Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Panacea Biotec Ltd Main Business Overview

13.13.5 Panacea Biotec Ltd Latest Developments

13.14 Bio-Med

13.14.1 Bio-Med Company Information

13.14.2 Bio-Med Vaccines Administered Orally Product Offered

13.14.3 Bio-Med Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Bio-Med Main Business Overview

13.14.5 Bio-Med Latest Developments

13.15 Halfkin Bio-Pharmaceuticals

13.15.1 Halfkin Bio-Pharmaceuticals Company Information

13.15.2 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Offered

13.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview

13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

Table 1. Vaccines Administered Orally Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Vaccines Administered Orally Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Human

Table 4. Major Players of Animal

Table 5. Global Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)

Table 6. Global Vaccines Administered Orally Sales Market Share by Type (2017-2022)

Table 7. Global Vaccines Administered Orally Revenue by Type (2017-2022) & ($ million)

Table 8. Global Vaccines Administered Orally Revenue Market Share by Type (2017-2022)

Table 9. Global Vaccines Administered Orally Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)

Table 11. Global Vaccines Administered Orally Sales Market Share by Application (2017-2022)

Table 12. Global Vaccines Administered Orally Revenue by Application (2017-2022)

Table 13. Global Vaccines Administered Orally Revenue Market Share by Application (2017-2022)

Table 14. Global Vaccines Administered Orally Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Vaccines Administered Orally Sales by Company (2020-2022) & (K Units)

Table 16. Global Vaccines Administered Orally Sales Market Share by Company (2020-2022)

Table 17. Global Vaccines Administered Orally Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Vaccines Administered Orally Revenue Market Share by Company (2020-2022)

Table 19. Global Vaccines Administered Orally Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Vaccines Administered Orally Producing Area Distribution and Sales Area

Table 21. Players Vaccines Administered Orally Products Offered

Table 22. Vaccines Administered Orally Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Vaccines Administered Orally Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Vaccines Administered Orally Sales Market Share Geographic Region (2017-2022)

Table 27. Global Vaccines Administered Orally Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Vaccines Administered Orally Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Vaccines Administered Orally Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Vaccines Administered Orally Sales Market Share by Country/Region (2017-2022)

Table 31. Global Vaccines Administered Orally Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Vaccines Administered Orally Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)

Table 34. Americas Vaccines Administered Orally Sales Market Share by Country (2017-2022)

Table 35. Americas Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Vaccines Administered Orally Revenue Market Share by Country (2017-2022)

Table 37. Americas Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)

Table 38. Americas Vaccines Administered Orally Sales Market Share by Type (2017-2022)

Table 39. Americas Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)

Table 40. Americas Vaccines Administered Orally Sales Market Share by Application (2017-2022)

Table 41. APAC Vaccines Administered Orally Sales by Region (2017-2022) & (K Units)

Table 42. APAC Vaccines Administered Orally Sales Market Share by Region (2017-2022)

Table 43. APAC Vaccines Administered Orally Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Vaccines Administered Orally Revenue Market Share by Region (2017-2022)

Table 45. APAC Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)

Table 46. APAC Vaccines Administered Orally Sales Market Share by Type (2017-2022)

Table 47. APAC Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)

Table 48. APAC Vaccines Administered Orally Sales Market Share by Application (2017-2022)

Table 49. Europe Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)

Table 50. Europe Vaccines Administered Orally Sales Market Share by Country (2017-2022)

Table 51. Europe Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Vaccines Administered Orally Revenue Market Share by Country (2017-2022)

Table 53. Europe Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)

Table 54. Europe Vaccines Administered Orally Sales Market Share by Type (2017-2022)

Table 55. Europe Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)

Table 56. Europe Vaccines Administered Orally Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Vaccines Administered Orally Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Vaccines Administered Orally Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Vaccines Administered Orally

Table 66. Key Market Challenges & Risks of Vaccines Administered Orally

Table 67. Key Industry Trends of Vaccines Administered Orally

Table 68. Vaccines Administered Orally Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Vaccines Administered Orally Distributors List

Table 71. Vaccines Administered Orally Customer List

Table 72. Global Vaccines Administered Orally Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Vaccines Administered Orally Sales Market Forecast by Region

Table 74. Global Vaccines Administered Orally Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Vaccines Administered Orally Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Vaccines Administered Orally Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Vaccines Administered Orally Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Vaccines Administered Orally Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Vaccines Administered Orally Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Vaccines Administered Orally Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Vaccines Administered Orally Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Vaccines Administered Orally Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Vaccines Administered Orally Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Vaccines Administered Orally Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Vaccines Administered Orally Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck Vaccines Administered Orally Product Offered

Table 94. Merck Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Merck Main Business

Table 96. Merck Latest Developments

Table 97. GSK Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 98. GSK Vaccines Administered Orally Product Offered

Table 99. GSK Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. GSK Main Business

Table 101. GSK Latest Developments

Table 102. Sanofi Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 103. Sanofi Vaccines Administered Orally Product Offered

Table 104. Sanofi Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Sanofi Main Business

Table 106. Sanofi Latest Developments

Table 107. Lanzhou Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 108. Lanzhou Institute Vaccines Administered Orally Product Offered

Table 109. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Lanzhou Institute Main Business

Table 111. Lanzhou Institute Latest Developments

Table 112. Serum Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 113. Serum Institute Vaccines Administered Orally Product Offered

Table 114. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Serum Institute Main Business

Table 116. Serum Institute Latest Developments

Table 117. Valneva Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 118. Valneva Vaccines Administered Orally Product Offered

Table 119. Valneva Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Valneva Main Business

Table 121. Valneva Latest Developments

Table 122. Shanghai United Cell Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 123. Shanghai United Cell Vaccines Administered Orally Product Offered

Table 124. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Shanghai United Cell Main Business

Table 126. Shanghai United Cell Latest Developments

Table 127. Bibcol Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 128. Bibcol Vaccines Administered Orally Product Offered

Table 129. Bibcol Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Bibcol Main Business

Table 131. Bibcol Latest Developments

Table 132. PaxVax Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 133. PaxVax Vaccines Administered Orally Product Offered

Table 134. PaxVax Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. PaxVax Main Business

Table 136. PaxVax Latest Developments

Table 137. Vabiotech Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 138. Vabiotech Vaccines Administered Orally Product Offered

Table 139. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Vabiotech Main Business

Table 141. Vabiotech Latest Developments

Table 142. Tiantan Biological Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 143. Tiantan Biological Vaccines Administered Orally Product Offered

Table 144. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Tiantan Biological Main Business

Table 146. Tiantan Biological Latest Developments

Table 147. EuBiologics Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 148. EuBiologics Vaccines Administered Orally Product Offered

Table 149. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. EuBiologics Main Business

Table 151. EuBiologics Latest Developments

Table 152. Panacea Biotec Ltd Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 153. Panacea Biotec Ltd Vaccines Administered Orally Product Offered

Table 154. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Panacea Biotec Ltd Main Business

Table 156. Panacea Biotec Ltd Latest Developments

Table 157. Bio-Med Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 158. Bio-Med Vaccines Administered Orally Product Offered

Table 159. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. Bio-Med Main Business

Table 161. Bio-Med Latest Developments

Table 162. Halfkin Bio-Pharmaceuticals Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 163. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Offered

Table 164. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. Halfkin Bio-Pharmaceuticals Main Business

Table 166. Halfkin Bio-Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Vaccines Administered Orally

Figure 2. Vaccines Administered Orally Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vaccines Administered Orally Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Vaccines Administered Orally Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Vaccines Administered Orally Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Human

Figure 10. Product Picture of Animal

Figure 11. Global Vaccines Administered Orally Sales Market Share by Type in 2021

Figure 12. Global Vaccines Administered Orally Revenue Market Share by Type (2017-2022)

Figure 13. Vaccines Administered Orally Consumed in Public

Figure 14. Global Vaccines Administered Orally Market: Public (2017-2022) & (K Units)

Figure 15. Vaccines Administered Orally Consumed in Private

Figure 16. Global Vaccines Administered Orally Market: Private (2017-2022) & (K Units)

Figure 17. Global Vaccines Administered Orally Sales Market Share by Application (2017-2022)

Figure 18. Global Vaccines Administered Orally Revenue Market Share by Application in 2021

Figure 19. Vaccines Administered Orally Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Vaccines Administered Orally Revenue Market Share by Company in 2021

Figure 21. Global Vaccines Administered Orally Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Vaccines Administered Orally Revenue Market Share by Geographic Region in 2021

Figure 23. Global Vaccines Administered Orally Sales Market Share by Region (2017-2022)

Figure 24. Global Vaccines Administered Orally Revenue Market Share by Country/Region in 2021

Figure 25. Americas Vaccines Administered Orally Sales 2017-2022 (K Units)

Figure 26. Americas Vaccines Administered Orally Revenue 2017-2022 ($ Millions)

Figure 27. APAC Vaccines Administered Orally Sales 2017-2022 (K Units)

Figure 28. APAC Vaccines Administered Orally Revenue 2017-2022 ($ Millions)

Figure 29. Europe Vaccines Administered Orally Sales 2017-2022 (K Units)

Figure 30. Europe Vaccines Administered Orally Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Vaccines Administered Orally Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Vaccines Administered Orally Revenue 2017-2022 ($ Millions)

Figure 33. Americas Vaccines Administered Orally Sales Market Share by Country in 2021

Figure 34. Americas Vaccines Administered Orally Revenue Market Share by Country in 2021

Figure 35. United States Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Vaccines Administered Orally Sales Market Share by Region in 2021

Figure 40. APAC Vaccines Administered Orally Revenue Market Share by Regions in 2021

Figure 41. China Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Vaccines Administered Orally Sales Market Share by Country in 2021

Figure 48. Europe Vaccines Administered Orally Revenue Market Share by Country in 2021

Figure 49. Germany Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country in 2021

Figure 56. Egypt Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Vaccines Administered Orally in 2021

Figure 62. Manufacturing Process Analysis of Vaccines Administered Orally

Figure 63. Industry Chain Structure of Vaccines Administered Orally

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles